![](https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png)
FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity
For Immediate Release: September 24, 2019 The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of 14 lots of prescription ranitidine capsules distributed by Sandoz Inc., used to decrease the amount …